The report "Vaccine Adjuvants Market by Product (Mineral Salt-based Adjuvant, Tensoactive Adjuvants, Adjuvant Emulsions, Liposome Adjuvants, Carbohydrate Adjuvants, Bacteria-derived Adjuvants, Virus-like Particles (VLP), Others), by Usage (Active Immunostimulants, Carriers, Vehicle Adjuvants), by Disease Type (Infectious Disease, Cancer), by Application (Research Applications, Commercial Applications) - Global Forecasts to 2030"
The report "Venous Thromboembolism Devices Market by Type of Device (Compression Stockings, Gradual or medical compression stockings, Anti-embolism stockings, Nonmedical support hosiery, Intermitted pneumatic compression devices, Inferior vena cava filters, Retrievable IVC filters, Permanent IVC Filters), by Disease Type ( Deep vein thrombosis, Pulmonary embolism) by End-User (Hospitals, Diagnostic Centers, Ambulatory surgical Centres) - Global Forecasts to 2030"
The report "Tumor Ablation Market by Function (Automated/Robotic Ablation, Conventional Ablation Devices), by Technology (Hyperthermic Ablation, Radiofrequency Ablation, Microwave Ablation, Laser Ablation, Ultrasound Ablation, Cryoablation), by Application (Primary Lung Cancer, Metastatic Diseases, Pain Palliation), by End User (Hospitals, Oncology Institutes, Diagnostic Centres) - Global Forecasts to 2030"
The global small molecule CDMO market size was valued at USD 40.6 billion in 2023 and is poised to grow at a significant CAGR of 6.4% during the forecast period 2024-30. It also includes market size and projection estimations for each of the five major regions from 2024 to 2030. The research report includes historical data, trending features, and market growth estimates for the future. Furthermore, the study includes a global and regional estimation and is further split by nations and categories within each region.
The report "Regenerative Medicine Market by Product Type (Biologically Derived Materials, Genetically Engineered Materials, Synthetic Materials, Pharmaceuticals, Others), by Technology (Gene therapy, Small Molecules and Biologicals, Cell Therapy, Tissue Engineering), by Application (Dermatology, Cardiovascular, Orthopaedic, Oncology, Wound healing, Neurology, Ophthalmology, Others), by End-user (Hospitals, Clinics, Research Laboratories, Others) - Global Forecasts to 2030"
The report "Merkel Cell Carcinoma Treatment Market by Drugs (Chemotherapy (Antimetabolites, Alkylating agents, Antibiotics, Taxanes, Topoisomerase inhibitors) Immunotherapy, Combination Therapies, Others), By Distribution Channel (Hospitals, Oncology research institutes, Ambulatory surgical centres, Retail Pharmacies, Online Pharmacies) - Global Forecasts to 2030"
View Full Report: https://www.precisionbusinessinsights.com/market-reports/global-merkel-c...
The sleep apnea devices market is projected to reach USD 5.6 billion in 2023, registering a Compound Annual Growth Rate (CAGR) of 6.2% during the forecast period 2024-2030. The growth of the market is majorly driven by the increasing awareness among the patient population in developing countries.
View Full Report: https://www.precisionbusinessinsights.com/market-reports/sleep-apnea-dev...
The hemodynamic monitoring systems market is projected to reach USD 1.14 billion in 2023, registering a Compound Annual Growth Rate (CAGR) of 6.3% during the forecast period 2024-2030. The growth of the market is majorly driven by the increasing prevalence of lifestyle diseases such as obesity, stroke, and diabetes.
View Full Report: https://www.precisionbusinessinsights.com/market-reports/global-hemodyna...
The enteral feeding devices market is projected to reach USD 3,243.71 million in 2023, registering at a Compound Annual Growth Rate (CAGR) of 5.8% during the forecast period 2024-2030. The growth of the market is majorly driven by the growing geriatric population and age-related chronic diseases.
View Full Report: https://www.precisionbusinessinsights.com/market-reports/global-enteral-...
The report "Influenza Vaccine Market by Vaccine Type (Quadrivalent and Trivalent), By Technology (Egg-based, and Cell Culture), By Age Group (Pediatric, and Adult), By Route of Administration (Injection, and Nasal Spray) - Global Forecasts to 2030", is projected to reach USD 7.32 billion in 2023, registering at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period 2024-2030. The growth of the influenza vaccine market is majorly driven by the rising government initiatives for spreading awareness.
